[go: up one dir, main page]

Kotyada et al., 2017 - Google Patents

Mechanistic Insights into the Differential Catalysis by RheB and Its Mutants: Y35A and Y35A-D65A

Kotyada et al., 2017

View PDF @Full View
Document ID
4394925878262204509
Author
Kotyada C
Maulik A
Srivastava A
Singh M
Publication year
Publication venue
ACS omega

External Links

Snippet

RheB GTPase is a Ras-related molecular switch, which regulates the mTOR signaling pathway by cycling between the active [guanosine triphosphate (GTP)] state and inactive [guanine diphosphate (GDP)] state. Impairment of GTPase activity because of mutations in …
Continue reading at pubs.acs.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Similar Documents

Publication Publication Date Title
Chen et al. Mutation-induced impacts on the switch transformations of the GDP-and GTP-bound K-Ras: insights from multiple replica Gaussian accelerated molecular dynamics and free energy analysis
Lu et al. Ras conformational ensembles, allostery, and signaling
Penkler et al. Allosteric modulation of human Hsp90α conformational dynamics
Slade et al. Protein arginine deiminase 2 binds calcium in an ordered fashion: implications for inhibitor design
Chakrabarti et al. Comparison of the conformations of KRAS isoforms, K-Ras4A and K-Ras4B, points to similarities and significant differences
Moroni et al. The structural asymmetry of mitochondrial Hsp90 (Trap1) determines fine tuning of functional dynamics
Jones et al. Role of the D-loops in allosteric control of ATP hydrolysis in an ABC transporter
Yao et al. Rapid characterization of allosteric networks with ensemble normal mode analysis
Bier et al. The molecular tweezer CLR01 stabilizes a disordered protein–protein interface
Jang et al. The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane
Hendus-Altenburger et al. Molecular basis for the binding and selective dephosphorylation of Na+/H+ exchanger 1 by calcineurin
Khaled et al. Conformational and dynamical effects of Tyr32 phosphorylation in K-Ras: molecular dynamics simulation and Markov state models analysis
Stafford et al. Electrostatic effects of mutations of Ras glutamine 61 measured using vibrational spectroscopy of a thiocyanate probe
Sayyed-Ahmad et al. Computational equilibrium thermodynamic and kinetic analysis of K-Ras dimerization through an effector binding surface suggests limited functional role
Liu et al. Large-scale analysis of breast cancer-related conformational changes in proteins using limited proteolysis
Lorton et al. A binary arginine methylation switch on histone H3 arginine 2 regulates its interaction with WDR5
Phuangsawai et al. Elucidating the origin of the esterase activity of human serum albumin using QM/MM calculations
Xu et al. Structural insights into the human mitochondrial pyruvate carrier complexes
Sgrignani et al. Molecular determinants for unphosphorylated STAT3 dimerization determined by integrative modeling
Höing et al. Recognition of a flexible protein loop in taspase 1 by multivalent supramolecular tweezers
Serapian et al. Atomistic simulations of the mechanisms of the poorly catalytic mitochondrial chaperone Trap1: insights into the effects of structural asymmetry on reactivity
Kuusk et al. Adoption of a turn conformation drives the binding affinity of p53 C-terminal domain peptides to 14-3-3σ
Mathivanan et al. Structure of a 14-3-3ε: FOXO3apS253 phosphopeptide complex reveals 14-3-3 isoform-specific binding of forkhead box class O transcription factor (FOXO) phosphoproteins
Astl et al. Allosteric mechanism of the Hsp90 chaperone interactions with cochaperones and client proteins by modulating communication spines of coupled regulatory switches: integrative atomistic modeling of Hsp90 signaling in dynamic interaction networks
Rath et al. Why are the truncated cyclin Es more effective CDK2 activators than the full-length isoforms?